REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
ROCKVILLE, Md., April 24, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 29, 2024.
- ROCKVILLE, Md., April 24, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 29, 2024.
- Panel: Gene Therapy: Positioning for CMC Success at Every Stage at 4:00 p.m. EDT
A live webcast of the panel can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com . - An archived replay of the webcast will be available for approximately 30 days following the presentation.